No Data
Wan Bond: Report for the third quarter of 2024
Express News | Wanbangde pharmaceutical holding group: net income in the first three quarters increased by 756.36% year-on-year.
Express News | Wanbangde pharmaceutical holding group: The current operation is normal with no significant undisclosed matters to disclose.
Express News | Latest research results from the team at Zhejiang Children's Hospital: Triptolide A is expected to treat diabetic nephropathy.
Wanbangde Pharmaceutical Names CFO
Wanbangde Pharmaceutical Holding Group: The financial director, who served for only eight months, resigned, and the chairman once again acted as the director. | Quick Read Announcement
①Tonight, Wanbangde announced that the Chief Financial Officer, Wang Tianfang, resigned after serving in the position for only 8 months; ②Chairman Zhao Shouming once again temporarily assumes the responsibilities of the CFO, having also done so when the former CFO Zhao Junhui resigned in June 2022; ③Within three years, Wanbangde's market cap has shrunk to only one-third of its previous value.
No Data
No Data